“When ‘the dust’ created by COVID-19 settles a little, we will face the same infective problems that we left behind.” Current hospital infection prevention efforts likely will remain overshadowed by COVID-19, while other previously identified hospital-acquired infections (HAIs) such as C. diff and MRSA are not going away and may, in fact, be due for a resurgence.
In a pay-for-performance world, hospitals face unique challenges in infection prevention. HAIs cost hospitals more than just fines. The hidden costs include patient satisfaction, negative reviews, and low grades and ratings.
However, there is a way to fight back and reduce these costs. Some hospitals have reduced the cost of HAIs from $300k to $3 million dollars. What’s their secret? Download the full article to learn more.